Scientific Director and Janssen Fellow
Janssen Research & Development, LLC
Spring House, Pennsylvania
Dr. Weng is Scientific Director, Janssen Fellow, and Head of Bioanalytical Chemistry and Pharmacokinetics, Janssen Research & Development, Johnson and Johnson, Spring House, PA, USA. Currently he supervises a department which has end to end responsibilities for all bioanalytical and preclinical TK activities (discovery and development) of the US programs, including outsourced in-life packages in China. In addition to support various programs at Janssen, current research interests of his group include novel bioanalytical quantitation for biomarkers, protein/peptides, and novel drug conjugates and unique formulations.
Dr. Weng has over 100 peer-reviewed journal publications, 13 book chapters, over 100 posters and over 25 podium presentations. He also co-edited two books on bioanalysis (Eliminating bottlenecks for efficient bioanalysis: practices and applications in drug discovery and development, 2014; Targeted biomarker quantitation by LC-MS, 2017) and one Special Focus Issue of Bioanalysis on Bioanalytical Laboratory Structure and Management (2014). He has been teaching short courses on DMPK at ASMS since 2011. He serves on the editorial advisory boards for three international scientific journals as well as on various scientific/organizational committees, most recently as the chairman for CPSA Shanghai 2013 and CPSA USA 2015. He is the current US regional editor for Biomedical Chromatography (Wiley)